The Indian Practitioner

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

The Role Of Omega-3 Fatty Acids in Gestational Diabetes Mellitus Management: A Review


Affiliations
1 M.Sc. Food & Nutrition, Research Associate, Sangath, New Delhi, India
2 M.Sc. Food & Nutrition, Intern, Public Health Foundation of India (PHFI), Gurugram, Haryana, India
3 Public Health Foundation of India (PHFI), Gurugram, Haryana, India
     

   Subscribe/Renew Journal


One in every seven births is affected by Gestational Diabetes Mellitus (GDM), globally. This ratio is expected to rise in future due to the continuous increase in the prevalence of GDM which poses as a risk for adverse health outcomes during pregnancy and delivery for both the mother and the baby. The scientific literature has already established the significance of GDM as a priority for maternal health and child health; however, a consensus on how to prevent GDM or minimize its adverse outcomes has not been reached. Where lifestyle interventions have shown a positive effect, prenatal supplementation with Omega-3 Polyunsaturated Fatty Acids (PUFA) has emerged as a new dietary intervention to control this condition. In this review, we assess the impact of prenatal Omega-3 supplementation prevention, management and pregnancy outcomes in GDM. The studies indicate towards a slight positive role of omega-3 supplementation in improved insulin resistance, lipid and glucose homeostasis, associated complications and pregnancy outcomes. However, this must be carefully interpreted in the light of limited studies retrieved in our search and quality of included publications. A thorough systematic review and meta-analysis of large high quality cohort studies or robust dietary intervention studies are urgently warranted to arrive at definite conclusions about omega-3’s role in GDM prevention and management.

Keywords

Gestational Diabetes Mellitus, Omega 3 Fatty Acids, Pregnancy, Maternal Hyperglycemia, Docosahexaenoic Acid.
Subscription Login to verify subscription
User
Notifications
Font Size


  • American Diabetes Association et al. Classification and diagnosis of diabetes. Diabetes Care. 2017;40(January):S11-S24. doi:10.2337/dc17-S005

  • IDF. IDF Diabetes Atlas.; 2015. doi:10.1289/image.ehp.v119.i03

  • Wahabi H, Fayed A, Esmaeil S, Mamdouh H, Kotb R. Prevalence and Complications of Pregestational and Gestational Diabetes in Saudi Women: Analysis from Riyadh Mother and Baby Cohort Study (RAHMA). Biomed Res Int. 2017. doi:10.1155/2017/6878263

  • Metzger BE, Persson B, Lowe LP, et al. Hyperglycemia and Adverse Pregnancy Outcome Study: Neonatal Glycemia. Pediatrics. 2010;126(6):e1545-e1552. doi:10.1542/peds.20092257

  • Shostrom DC V., Sun Y, Oleson JJ, Snetselaar LG, Bao W. History of Gestational Diabetes Mellitus in Relation to Cardiovascular Disease and Cardiovascular Risk Factors in US Women. Front Endocrinol (Lausanne). 2017;8:144. doi:10.3389/fendo.2017.00144

  • Kapustin JF. Postpartum management for gestational diabetes mellitus: Policy and practice implications. J Am Acad Nurse Pract. 2008;20(11):547-554. doi:10.1111/j.17457599.2008.00354.x

  • Poolsup N, Suksomboon N, Amin M. Effect of treatment of gestational diabetes mellitus: A systematic review and meta-analysis. PLoS One. 2014;9(3):1-9. doi:10.1371/journal. pone.0092485

  • Verc¸oza Viana L, Gross JL, Azevedo MJ. Dietary intervention in patients with gestational diabetes mellitus: A systematic review and meta-analysis of randomized clinical trials on maternal and newborn outcomes. Diabetes Care. 2014;37(12):3345-3355. doi:10.2337/dc14-1530

  • Dolatkhah N, Hajifaraji M, Abbasalizadeh F, Aghamohammadzadeh N, Mehrabi Y, Abbasi MM. Is there a value for probiotic supplements in gestational diabetes mellitus? A randomized clinical trial. J Heal Popul Nutr. 2015;33(1). doi:10.1186/s41043-015-0034-9

  • Jamilian M, Samimi M, Ebrahimi FA, et al. The effects of vitamin D and omega-3 fatty acid co-supplementation on glycemic control and lipid concentrations in patients with gestational diabetes. J Clin Lipidol. 2017;11(2):459-468. doi:10.1016/j.jacl.2017.01.011

  • Samimi M, Jamilian M, Asemi Z, Esmaillzadeh A. Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, doubleblind, placebo-controlled trial. Clin Nutr. 2014;34(3):388393. doi:10.1016/j.clnu.2014.06.005

  • Taghizadeh M, Jamilian M, Mazloomi M, Sanami M, Asemi Z. A randomized-controlled clinical trial investigating the effect of omega-3 fatty acids and vitamin E co-supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes. J Clin Lipidol. 2016;10(2):386-393. doi:10.1016/j.jacl.2015.12.017

  • Jamilian M, Samimi M, Kolahdooz F, Khalaji F, Razavi, Maryamalsadat Asemi Z. Omega-3 fatty acid supplementation affects pregnancy outcomes in gestational diabetes: a randomized, double-blind, placebo-controlled trial. J Matern Neonatal Med. 2015;29(4):669-675. doi:10.3109/14767058.2015.1015980

  • Jamilian M, Hashemi Dizaji S, Bahmani F, et al. A Randomized Controlled Clinical Trial Investigating the Effects of Omega-3 Fatty Acids and Vitamin E Co-Supplementation on Biomarkers of Oxidative Stress, Inflammation and Pregnancy Outcomes in Gestational Diabetes. Can J Diabetes. 2016;41(2):143-149. doi:10.1016/j.jcjd.2016.09.004

  • Djelti F, Merzouk H, Merzouk SA, Narce M. In vitro effects of oil’s fatty acids on T cell function in gestational diabetic pregnant women and their newborns. J Diabetes. 2015;7(4):512-522. doi:10.1111/1753-0407.12210

  • Barbieiri P, Nunes JC, Torres AG, et al. Indices of dietary fat quality during midpregnancy is associated with gestational diabetes. Nutrition. 2016;32(6):656-661. doi:10.1016/j.nut.2015.12.002

  • Mohanty AF, Siscovick DS, Williams MA, Thompson M Lou, Burbacher TM, Enquobahrie DA. Periconceptional seafood intake and pregnancy complications. Public Health Nutr. 2016;19(10):1795-1803. doi:10.1017/S136898001500316X

  • Meinilä J, Koivusalo SB, Valkama A, et al. Nutrient intake of pregnant women at high risk of gestational diabetes. Food Nutr Res. 2015;59(Sd 7):26676. doi:10.3402/fnr.v59.26676

  • Min Y, Djahanbakhch O, Hutchinson J, et al. Efficacy of docosahexaenoic acid-enriched formula to enhance maternal and fetal blood docosahexaenoic acid levels: Randomized double-blinded placebo-controlled trial of pregnant women with gestational diabetes mellitus. Clin Nutr. 2015;35(3):608614. doi:10.1016/j.clnu.2015.05.020

  • Pagán A, Prieto-Sánchez MT, Blanco-Carnero JE, et al. Materno-fetal transfer of docosahexaenoic acid is impaired by gestational diabetes mellitus. Am J Physiol Metab. 2013;305(7):E826-E833. doi:10.1152/ajpendo.00291.2013

  • Prieto-Sánchez MT, Ruiz-Palacios M, Blanco-Carnero JE, et al. Placental MFSD2a transporter is related to decreased DHA in cord blood of women with treated gestational diabetes. Clin Nutr. 2017;36(2):513-521. doi:10.1016/j.clnu.2016.01.014

  • Araújo JR, Correia-Branco A, Ramalho C, Keating E, Martel F. Gestational diabetes mellitus decreases placental uptake of long-chain polyunsaturated fatty acids: involvement of long-chain acyl-CoA synthetase. J Nutr Biochem. 2013;24(10):1741-1750. doi:10.1016/j.jnutbio.2013.03.003

  • Larqué E, Pagán A, Prieto MT, et al. Placental Fatty Acid Transfer: A key factor in fetal growth. Ann Nutr Metab 2014;64:247-253. doi:10.1159/000365028

  • Zornoza-Moreno M, Fuentes-Hernández S, Carrión V, et al. Is low docosahexaenoic acid associated with disturbed rhythms and neurodevelopment in offsprings of diabetic mothers? Eur J Clin Nutr. 2014;68(8):931-937. doi:10.1038/ ejcn.2014.104

  • Zhao JP, Levy E, Shatenstein B, et al. Longitudinal circulating concentrations of long-chain polyunsaturated fatty acids in the third trimester of pregnancy in gestational diabetes. Diabet Med. 2016;33(7):939-946. doi:10.1111/dme.12978

  • Zhao J, Levy E, Fraser WD, et al. Circulating Docosahexaenoic Acid Levels Are Associated with Fetal Insulin Sensitivity. 2014;9(1):1-7. doi:10.1371/journal.pone.0085054

  • Léveillé P, Ardilouze J-L, Pasquier J-C, Deacon C, Whittingstall K, Plourde M. Fatty acid profile in cord blood of neonates born to optimally controlled gestational diabetes mellitus. Prostaglandins, Leukot Essent Fat Acids. 2016;115:48-52. doi:10.1016/j.plefa.2016.10.006

  • Azulay Chertok IR, Haile ZT, Eventov-Friedman S, Silanikove N, Argov-Argaman N. Influence of gestational diabetes mellitus on fatty acid concentrations in human colostrum. Nutrition. 2017;36:17-21. doi:10.1016/j.nut.2016.12.001

  • Min Y, Djahanbakhch O, Hutchinson J, et al. Efficacy of docosahexaenoic acid-enriched formula to enhance maternal and fetal blood docosahexaenoic acid levels: Randomized double-blinded placebo-controlled trial of pregnant women with gestational diabetes mellitus. Clin Nutr. 2016;35(3):608614. doi:10.1016/j.clnu.2015.05.020

  • Silva-zolezzi I, Samuel TM. Maternal nutrition : opportunities in the prevention of gestational diabetes. 2016;75:32-50. doi:10.1093/nutrit/nuw033

  • Enovilla HEOR. Gestational Diabetes Mellitus Upsets the Proportion of Fatty Acids in Umbilical. 2009;(October 2008):120-122. doi:10.2337/dc08-0679.

  • Santangelo C, Zicari A, Mandosi E, et al. Could gestational diabetes mellitus be managed through dietary bioactive compounds ? Current knowledge and future perspectives. 2016:1129-1144. doi:10.1017/S0007114516000222

  • Zhou SJ, Yelland L, Mcphee AJ, Quinlivan J, Gibson RA, Makrides M. Fish-oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia 1 – 3. 2012:1378-1384. doi:10.3945/ajcn.111.033217.1

  • Bowers K, Tobias DK, Yeung E, Hu FB, Zhang C. A prospective study of prepregnancy dietary fat intake and risk of. 2012;(C). doi:10.3945/ajcn.111.026294.

  • Simopoulos AP. Evolutionary aspects of diet, the omega-6/ omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother. 2006;60(9):502507. doi:10.1016/j.biopha.2006.07.080

  • Shearer GC, Savinova O V, Harris WS. Fish oil -- how does it reduce plasma triglycerides? Biochim Biophys Acta. 2012;1821(5):843-851. doi:10.1016/j.bbalip.2011.10.011

  • Gould J, Smithers L, Makrides M. The effect of maternal omega-3 (n-3) LCPUFA supplementation during pregnancy on early childhood cognitive and visual development: a systematic review and meta-analysis of randomized controlled trials. Am J …. 2013;97(May):531-544. doi:10.3945/ ajcn.112.045781.1

  • Colombo J, Kannass KN, Jill Shaddy D, et al. Maternal DHA and the Development of Attention in Infancy and Toddlerhood. Child Dev. 2004;75(4):1254-1267. doi:10.1111/ j.1467-8624.2004.00737.x

  • Saccone G, Saccone I, Berghella V, Saccone G, Saccone I, Berghella V. Omega-3 long-chain polyunsaturated fatty acids and fish oil supplementation during pregnancy : which evidence ? Omega-3 long-chain polyunsaturated fatty acids and fish oil supplementation during pregnancy : which evidence ? 2015;7058(September). doi:10.3109/14767058.2015.10 86742

  • Yessoufou A, Nekoua MP, Gbankoto A, Mashalla Y, Moutairou K. Beneficial Effects of Omega-3 Polyunsaturated Fatty Acids in Gestational Diabetes : Consequences in Macrosomia and Adulthood Obesity. 2015;2015.


Abstract Views: 211

PDF Views: 0




  • The Role Of Omega-3 Fatty Acids in Gestational Diabetes Mellitus Management: A Review

Abstract Views: 211  |  PDF Views: 0

Authors

Ruchi Sareen
M.Sc. Food & Nutrition, Research Associate, Sangath, New Delhi, India
Aashna Arora
M.Sc. Food & Nutrition, Intern, Public Health Foundation of India (PHFI), Gurugram, Haryana, India
Monica Chaudhry
Public Health Foundation of India (PHFI), Gurugram, Haryana, India
Shweta Khandelwal
Public Health Foundation of India (PHFI), Gurugram, Haryana, India

Abstract


One in every seven births is affected by Gestational Diabetes Mellitus (GDM), globally. This ratio is expected to rise in future due to the continuous increase in the prevalence of GDM which poses as a risk for adverse health outcomes during pregnancy and delivery for both the mother and the baby. The scientific literature has already established the significance of GDM as a priority for maternal health and child health; however, a consensus on how to prevent GDM or minimize its adverse outcomes has not been reached. Where lifestyle interventions have shown a positive effect, prenatal supplementation with Omega-3 Polyunsaturated Fatty Acids (PUFA) has emerged as a new dietary intervention to control this condition. In this review, we assess the impact of prenatal Omega-3 supplementation prevention, management and pregnancy outcomes in GDM. The studies indicate towards a slight positive role of omega-3 supplementation in improved insulin resistance, lipid and glucose homeostasis, associated complications and pregnancy outcomes. However, this must be carefully interpreted in the light of limited studies retrieved in our search and quality of included publications. A thorough systematic review and meta-analysis of large high quality cohort studies or robust dietary intervention studies are urgently warranted to arrive at definite conclusions about omega-3’s role in GDM prevention and management.

Keywords


Gestational Diabetes Mellitus, Omega 3 Fatty Acids, Pregnancy, Maternal Hyperglycemia, Docosahexaenoic Acid.

References